{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T17:36:24Z","timestamp":1781804184000,"version":"3.54.5"},"reference-count":67,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.vaccine.2011.03.031","type":"journal-article","created":{"date-parts":[[2011,4,8]],"date-time":"2011-04-08T17:38:58Z","timestamp":1302284338000},"page":"3773-3781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Inactivated and live, attenuated influenza vaccines protect mice against influenza:Streptococcus pyogenes super-infections"],"prefix":"10.1016","volume":"29","author":[{"given":"Michael S.","family":"Chaussee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather R.","family":"Sandbulte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret J.","family":"Schuneman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank P.","family":"DePaula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie A.","family":"Addengast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn H.","family":"Schlenker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor C.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vaccine.2011.03.031_bib0005","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/aje\/kwh227","article-title":"Influenza and the winter increase in mortality in the United States, 1959\u20131999","volume":"160","author":"Reichert","year":"2004","journal-title":"Am J Epidemiol"},{"issue":"7","key":"10.1016\/j.vaccine.2011.03.031_bib0010","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1086\/591708","article-title":"Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness","volume":"198","author":"Morens","year":"2008","journal-title":"J Infect Dis"},{"issue":"1 Suppl.","key":"10.1016\/j.vaccine.2011.03.031_bib0015","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1097\/01.inf.0000108197.81270.35","article-title":"Respiratory viruses predisposing to bacterial infections: role of neuraminidase","volume":"23","author":"Peltola","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.vaccine.2011.03.031_bib0020","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nm1765","article-title":"Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection","volume":"14","author":"Sun","year":"2008","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.vaccine.2011.03.031_bib0025","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1086\/341462","article-title":"Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor","volume":"186","author":"McCullers","year":"2002","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2011.03.031_bib0030","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1473-3099(06)70466-2","article-title":"Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness","volume":"6","author":"Brundage","year":"2006","journal-title":"Lancet Infect Dis"},{"issue":"38","key":"10.1016\/j.vaccine.2011.03.031_bib0035","first-page":"1071","article-title":"Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) \u2013 United States, May\u2013August 2009","volume":"58","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"10.1016\/j.vaccine.2011.03.031_bib0040","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/INF.0b013e3181df2c70","article-title":"Association of 2009 pandemic influenza A (H1N1) infection and increased hospitalization with parapneumonic empyema in children in Utah","volume":"29","author":"Ampofo","year":"2010","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.vaccine.2011.03.031_bib0045","doi-asserted-by":"crossref","DOI":"10.2807\/ese.16.05.19785-en","article-title":"Increase in invasive Streptococcus pyogenes and Streptococcus pneumoniae infections in England, December 2010 to January 2011","volume":"16","author":"Zakikhany","year":"2011","journal-title":"Euro Surveill"},{"issue":"4","key":"10.1016\/j.vaccine.2011.03.031_bib0050","doi-asserted-by":"crossref","first-page":"D17","DOI":"10.1016\/j.vaccine.2008.07.048","article-title":"Efficacy and effectiveness of influenza vaccination","volume":"26","author":"Nichol","year":"2008","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2011.03.031_bib0055","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/INF.0b013e318174e0f8","article-title":"Duration of protection provided by live attenuated influenza vaccine in children","volume":"27","author":"Ambrose","year":"2008","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.vaccine.2011.03.031_bib0060","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1086\/589885","article-title":"Prevention of symptomatic seasonal influenza in 2005\u20132006 by inactivated and live attenuated vaccines","volume":"198","author":"Ohmit","year":"2008","journal-title":"J Infect Dis"},{"issue":"24","key":"10.1016\/j.vaccine.2011.03.031_bib0065","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1056\/NEJMoa061850","article-title":"Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines","volume":"355","author":"Ohmit","year":"2006","journal-title":"N Engl J Med"},{"issue":"21\u201322","key":"10.1016\/j.vaccine.2011.03.031_bib0070","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1016\/j.vaccine.2003.12.024","article-title":"Vaccination with formalin-inactivated influenza vaccine protects mice against lethal influenza Streptococcus pyogenes superinfection","volume":"22","author":"Okamoto","year":"2004","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2011.03.031_bib0075","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1128\/JVI.02621-09","article-title":"Contribution of vaccine-induced immunity toward either the HA or the NA component of influenza viruses limits secondary bacterial complications","volume":"84","author":"Huber","year":"2010","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2011.03.031_bib0080","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1097\/00006454-200005001-00010","article-title":"Prevention of otitis media in children with live attenuated influenza vaccine given intranasally","volume":"19","author":"Belshe","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"27\u201328","key":"10.1016\/j.vaccine.2011.03.031_bib0085","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1016\/j.vaccine.2008.04.041","article-title":"Influenza immunization and subsequent diagnoses of group A streptococcus-illnesses among U.S, Army trainees, 2002\u20132006","volume":"26","author":"Lee","year":"2008","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2011.03.031_bib0090","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1086\/592165","article-title":"Planning for an influenza pandemic: thinking beyond the virus","volume":"198","author":"McCullers","year":"2008","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2011.03.031_bib0095","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.vaccine.2008.12.023","article-title":"A multi-valent vaccine approach that elicits broad immunity within an influenza subtype","volume":"27","author":"Huber","year":"2009","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2011.03.031_bib0100","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/CVI.00156-06","article-title":"Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza","volume":"13","author":"Huber","year":"2006","journal-title":"Clin Vaccine Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2011.03.031_bib0105","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1086\/368163","article-title":"Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae","volume":"187","author":"McCullers","year":"2003","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2011.03.031_bib0110","first-page":"345","article-title":"Origin and progress of the 1968\u201369 Hong Kong influenza epidemic","volume":"41","author":"Cockburn","year":"1969","journal-title":"Bull World Health Organ"},{"issue":"15","key":"10.1016\/j.vaccine.2011.03.031_bib0115","doi-asserted-by":"crossref","first-page":"10078","DOI":"10.1073\/pnas.152298499","article-title":"Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence","volume":"99","author":"Beres","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"10.1016\/j.vaccine.2011.03.031_bib0120","doi-asserted-by":"crossref","first-page":"5411","DOI":"10.1128\/IAI.00373-09","article-title":"A naturally occurring Rgg variant in serotype M3 Streptococcus pyogenes does not activate speB expression due to altered specificity of DNA binding","volume":"77","author":"Kappeler","year":"2009","journal-title":"Infect Immun"},{"issue":"42","key":"10.1016\/j.vaccine.2011.03.031_bib0125","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1016\/j.vaccine.2008.07.086","article-title":"Live, attenuated influenza virus (LAIV) vehicles are strong inducers of immunity toward influenza B virus","volume":"26","author":"Huber","year":"2008","journal-title":"Vaccine"},{"issue":"RR-8","key":"10.1016\/j.vaccine.2011.03.031_bib0130","first-page":"1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009","volume":"58","author":"Fiore","year":"2009","journal-title":"MMWR Recomm Rep"},{"issue":"2","key":"10.1016\/j.vaccine.2011.03.031_bib0135","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1128\/JVI.78.2.995-998.2004","article-title":"Imparting temperature sensitivity and attenuation in ferrets to A\/Puerto Rico\/8\/34 influenza virus by transferring the genetic signature for temperature sensitivity from cold-adapted A\/Ann Arbor\/6\/60","volume":"78","author":"Jin","year":"2004","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2011.03.031_bib0140","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1086\/500247","article-title":"Live attenuated influenza vaccine is safe and immunogenic in immunocompromised ferrets","volume":"193","author":"Huber","year":"2006","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2011.03.031_bib0145","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.4049\/jimmunol.166.12.7381","article-title":"Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections","volume":"166","author":"Huber","year":"2001","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.03.031_bib0150","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/15476910490438351","article-title":"Immunologic effector mechanisms in animal models of occupational asthma","volume":"1","author":"Regal","year":"2004","journal-title":"J Immunotoxicol"},{"issue":"5","key":"10.1016\/j.vaccine.2011.03.031_bib0155","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1348-0421.1992.tb02045.x","article-title":"Definition and application of a histopathological scoring scheme for an animal model of acute Mycoplasma pneumoniae pulmonary infection","volume":"36","author":"Cimolai","year":"1992","journal-title":"Microbiol Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2011.03.031_bib0160","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1213\/01.ANE.0000144775.19385.8C","article-title":"Attenuation of acute lung injury with propofol in endotoxemia","volume":"100","author":"Takao","year":"2005","journal-title":"Anesth Analg"},{"issue":"34","key":"10.1016\/j.vaccine.2011.03.031_bib0165","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1016\/j.vaccine.2008.06.012","article-title":"FDA\/NIH\/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10\u201311, 2007","volume":"26","author":"Eichelberger","year":"2008","journal-title":"Vaccine"},{"issue":"23","key":"10.1016\/j.vaccine.2011.03.031_bib0170","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1016\/S0264-410X(03)00262-7","article-title":"Route of administration is the prime determinant of IgA and IgG2a responses in the respiratory tract of mice to the cold-adapted live attenuated influenza A donor strain A\/Leningrad\/134\/17\/57","volume":"21","author":"Wareing","year":"2003","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2011.03.031_bib0175","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1086\/314996","article-title":"Intranasal interleukin-12 is a powerful adjuvant for protective mucosal immunity","volume":"180","author":"Arulanandam","year":"1999","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2011.03.031_bib0180","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1086\/596051","article-title":"Treatment with protein synthesis inhibitors improves outcomes of secondary bacterial pneumonia after influenza","volume":"199","author":"Karlstrom","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.03.031_bib0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2010.06.012","article-title":"Lower respiratory tract infection in cynomolgus macaques (Macaca fascicularis) infected with group A Streptococcus","author":"Olsen","year":"2010","journal-title":"Microb Pathog"},{"issue":"11","key":"10.1016\/j.vaccine.2011.03.031_bib0190","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of group A streptococcal diseases","volume":"5","author":"Carapetis","year":"2005","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2011.03.031_bib0195","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/ni1530","article-title":"Protective immunity and susceptibility to infectious diseases: lessons from the 1918 influenza pandemic","volume":"8","author":"Ahmed","year":"2007","journal-title":"Nat Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2011.03.031_bib0200","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archinte.163.4.467","article-title":"Clinical and epidemiologic features of group a streptococcal pneumonia in Ontario, Canada","volume":"163","author":"Muller","year":"2003","journal-title":"Arch Intern Med"},{"issue":"7","key":"10.1016\/j.vaccine.2011.03.031_bib0205","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1128\/JVI.77.7.4104-4112.2003","article-title":"Influenza A virus-infected hosts boost an invasive type of Streptococcus pyogenes infection in mice","volume":"77","author":"Okamoto","year":"2003","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2011.03.031_bib0210","doi-asserted-by":"crossref","first-page":"6068","DOI":"10.1128\/IAI.72.10.6068-6075.2004","article-title":"The Streptococcus pyogenes capsule is required for adhesion of bacteria to virus-infected alveolar epithelial cells and lethal bacterial-viral superinfection","volume":"72","author":"Okamoto","year":"2004","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2011.03.031_bib0215","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1128\/IAI.01943-06","article-title":"Filamentous influenza A virus infection predisposes mice to fatal septicemia following superinfection with Streptococcus pneumoniae serotype 3","volume":"75","author":"Speshock","year":"2007","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2011.03.031_bib0220","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1086\/511989","article-title":"The 1918 influenza pandemic: insights for the 21st century","volume":"195","author":"Morens","year":"2007","journal-title":"J Infect Dis"},{"issue":"26","key":"10.1016\/j.vaccine.2011.03.031_bib0225","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1056\/NEJMc0908216","article-title":"Bacterial pathogens and death during the 1918 influenza pandemic","volume":"361","author":"Chien","year":"2009","journal-title":"N Engl J Med"},{"issue":"9261","key":"10.1016\/j.vaccine.2011.03.031_bib0230","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0140-6736(00)04237-9","article-title":"Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65years or older: a prospective study","volume":"357","author":"Christenson","year":"2001","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.vaccine.2011.03.031_bib0235","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1056\/NEJMoa022678","article-title":"Effectiveness of pneumococcal polysaccharide vaccine in older adults","volume":"348","author":"Jackson","year":"2003","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2011.03.031_bib0240","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1586\/14760584.8.2.159","article-title":"Experience with pneumococcal conjugate vaccine in Norway","volume":"8","author":"Aaberge","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"4","key":"10.1016\/j.vaccine.2011.03.031_bib0245","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1128\/IAI.70.4.2171-2177.2002","article-title":"Immunogenicity of a 26-valent group A streptococcal vaccine","volume":"70","author":"Hu","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.031_bib0250","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-0-387-73960-1_5","article-title":"Current status of group A streptococcal vaccine development","volume":"609","author":"Dale","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.vaccine.2011.03.031_bib0255","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/epirev\/mxj003","article-title":"Immunization to protect the US Armed Forces: heritage, current practice, and prospects","volume":"28","author":"Grabenstein","year":"2006","journal-title":"Epidemiol Rev"},{"issue":"5","key":"10.1016\/j.vaccine.2011.03.031_bib0260","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/01.inf.0000217370.83948.51","article-title":"Effectiveness of inactivated influenza vaccine for prevention of otitis media in children","volume":"25","author":"Ozgur","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"10.1016\/j.vaccine.2011.03.031_bib0265","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1001\/archpedi.1995.02170230067009","article-title":"Influenza A vaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care","volume":"149","author":"Clements","year":"1995","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"3","key":"10.1016\/j.vaccine.2011.03.031_bib0270","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3201\/eid0503.990308","article-title":"Respiratory diseases among U.S. military personnel: countering emerging threats","volume":"5","author":"Gray","year":"1999","journal-title":"Emerg Infect Dis"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2011.03.031_bib0275","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.virusres.2004.02.031","article-title":"Current status of live attenuated influenza virus vaccine in the US","volume":"103","author":"Belshe","year":"2004","journal-title":"Virus Res"},{"issue":"3","key":"10.1016\/j.vaccine.2011.03.031_bib0280","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1086\/315323","article-title":"Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine","volume":"181","author":"Belshe","year":"2000","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2011.03.031_bib0285","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/infdis\/173.6.1313","volume":"173","author":"Gruber","year":"1996","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2011.03.031_bib0290","first-page":"373","article-title":"Effect of virus infection on the inflammatory response. Depression of macrophage accumulation in influenza-infected mice","volume":"85","author":"Kleinerman","year":"1976","journal-title":"Am J Pathol"},{"issue":"9","key":"10.1016\/j.vaccine.2011.03.031_bib0295","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1128\/iai.58.9.2809-2814.1990","article-title":"Pulmonary antibacterial defenses during mild and severe influenza virus infection","volume":"58","author":"Nickerson","year":"1990","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2011.03.031_bib0300","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/excr.1997.3602","article-title":"Characterization of influenza virus-induced death of J774.1 macrophages","volume":"234","author":"Lowy","year":"1997","journal-title":"Exp Cell Res"},{"issue":"5","key":"10.1016\/j.vaccine.2011.03.031_bib0305","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.4049\/jimmunol.113.5.1562","article-title":"Depression of human monocyte chemotaxis by herpes simplex and influenza viruses","volume":"113","author":"Kleinerman","year":"1974","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2011.03.031_bib0310","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/infdis\/119.6.541","article-title":"Interaction of influenza virus with leukocytes and its effect on phagocytosis","volume":"119","author":"Sawyer","year":"1969","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2011.03.031_bib0315","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/clinids\/10.2.326","article-title":"Depression of neutrophil function induced by viruses and its role in secondary microbial infections","volume":"10","author":"Abramson","year":"1988","journal-title":"Rev Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2011.03.031_bib0320","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1182\/blood.V93.7.2395","article-title":"Influenza A virus accelerates neutrophil apoptosis and markedly potentiates apoptotic effects of bacteria","volume":"93","author":"Colamussi","year":"1999","journal-title":"Blood"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2011.03.031_bib0325","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0171-2985(11)80292-5","article-title":"Programmed cell death (apoptosis) in human monocytes infected by influenza A virus","volume":"190","author":"Fesq","year":"1994","journal-title":"Immunobiology"},{"issue":"2","key":"10.1016\/j.vaccine.2011.03.031_bib0330","doi-asserted-by":"crossref","first-page":"987","DOI":"10.4049\/jimmunol.1002664","article-title":"Seasonal FluMist vaccination induces cross-reactive T cell immunity against H1N1 (2009) influenza and secondary bacterial infections","volume":"186","author":"Sun","year":"2011","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2011.03.031_bib0335","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1086\/657144","article-title":"Efficacy of whole-cell killed bacterial vaccines in preventing pneumonia and death during the 1918 influenza pandemic","volume":"202","author":"Chien","year":"2010","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11003835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11003835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:17:37Z","timestamp":1759400257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11003835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":67,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0264410X11003835"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.03.031","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inactivated and live, attenuated influenza vaccines protect mice against influenza:Streptococcus pyogenes super-infections","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.03.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}